Denali Therapeutics Reports Full Year 2020 Financial Results and Business Highlights
SOUTH SAN FRANCISCO, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cro …
Discussion disabled.
Category: Dementia